{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:05:01Z","timestamp":1791032701886,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.beem.2006.07.001","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T12:09:23Z","timestamp":1158667763000},"page":"337-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Cortisol metabolism in hypertension"],"prefix":"10.1016","volume":"20","author":[{"given":"Fabian","family":"Hammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2006.07.001_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0002-8703(78)90307-1","article-title":"Low-renin (\u201cprimary\u201d) hyperaldosteronism. Differential diagnosis and distinction of sub-groups within the syndrome","volume":"95","author":"Ferriss","year":"1978","journal-title":"American Heart Journal"},{"key":"10.1016\/j.beem.2006.07.001_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1521-690X(03)00050-2","article-title":"Primary aldosteronism","volume":"17","author":"Stowasser","year":"2003","journal-title":"Best Practice & Research. Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2006.07.001_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.1.06019","article-title":"11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action","volume":"186","author":"Draper","year":"2005","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.07.001_bib5","first-page":"1325","article-title":"Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues","volume":"83","author":"Ricketts","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1074\/jbc.270.5.2305","article-title":"Lumenal orientation and post-translational modifications of the liver microsomal 11 beta-hydroxysteroid dehydrogenase","volume":"270","author":"Ozols","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.07.001_bib7","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1074\/jbc.M512635200","article-title":"Hexose-6-phosphate dehydrogenase Knock-out mice lack 11beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation","volume":"281","author":"Lavery","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2006.07.001_bib8","first-page":"480","article-title":"Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform","volume":"79","author":"Stewart","year":"1994","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/humrep\/13.4.799","article-title":"11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction","volume":"13","author":"Shams","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1016\/j.beem.2006.07.001_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.beem.2006.07.001_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1043-2760(00)00356-8","article-title":"Apparent mineralocorticoid excess","volume":"12","author":"Wilson","year":"2001","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib12","first-page":"135","article-title":"11 Beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess","volume":"18","author":"White","year":"1997","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2006.07.001_bib13","first-page":"2244","article-title":"Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess","volume":"83","author":"Dave-Sharma","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem-49-5-757","article-title":"A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol","volume":"49","author":"Ulick","year":"1979","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2265.1985.tb00160.x","article-title":"Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families","volume":"22","author":"Shackleton","year":"1985","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2006.07.001_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem-63-3-550","article-title":"The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism","volume":"63","author":"Monder","year":"1986","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI113592","article-title":"Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle","volume":"82","author":"Stewart","year":"1988","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.beem.2006.07.001_bib18","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.95.17.10200","article-title":"A genetic defect resulting in mild low-renin hypertension","volume":"95","author":"Wilson","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/j.beem.2006.07.001_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/jcem-70-1-200","article-title":"Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess","volume":"70","author":"Ulick","year":"1990","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0039-128X(96)00012-8","article-title":"Apparent mineralocorticoid excess: type I and type II","volume":"61","author":"Mantero","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2006.07.001_bib21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJM199812103392414","article-title":"Cure of apparent mineralocorticoid excess by kidney transplantation","volume":"339","author":"Palermo","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.07.001_bib22","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","article-title":"Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme","volume":"105","author":"Albiston","year":"1994","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.beem.2006.07.001_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/geno.1995.1231","article-title":"Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"29","author":"Agarwal","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.beem.2006.07.001_bib24","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1210\/jc.2003-030138","article-title":"Hypertension and the cortisol-cortisone shuttle","volume":"88","author":"Quinkler","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1016\/j.beem.2006.07.001_bib26","first-page":"3145","article-title":"Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib27","first-page":"2263","article-title":"A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess","volume":"80","author":"Wilson","year":"1995","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(96)90211-1","article-title":"Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene","volume":"347","author":"Stewart","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.07.001_bib29","first-page":"4054","article-title":"A new compound heterozygous mutation in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess","volume":"82","author":"Kitanaka","year":"1997","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/01.HYP.0000083340.57063.35","article-title":"Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene","volume":"42","author":"Lavery","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.HYP.34.4.638","article-title":"Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess","volume":"34","author":"Nunez","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00004872-199715120-00005","article-title":"Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state","volume":"15","author":"Li","year":"1997","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(53)91801-7","article-title":"Effects of liquorice and its derivatives on salt and water metabolism","volume":"1","author":"Card","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.07.001_bib34","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM199110243251706","article-title":"Licorice-induced hypermineralocorticoidism","volume":"325","author":"Farese","year":"1991","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.07.001_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jama.1968.03140330034006","article-title":"Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity","volume":"205","author":"Conn","year":"1968","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2006.07.001_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age","volume":"2","author":"Stewart","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2006.07.001_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1677\/joe.0.1350147","article-title":"Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney","volume":"135","author":"Kageyama","year":"1992","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.07.001_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.20.3.356","article-title":"Detection of glycyrrhetinic acid-like factors (GALFs) in human urine","volume":"20","author":"Morris","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.HYP.29.1.500","article-title":"Kidney 11 beta-HSD2 is inhibited by glycyrrhetinic acid-like factors in human urine","volume":"29","author":"Lo","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib40","first-page":"529","article-title":"Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase in hypertension","volume":"80","author":"Walker","year":"1995","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2265.1996.00853.x","article-title":"Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man","volume":"45","author":"Palermo","year":"1996","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2006.07.001_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004872-198308000-00014","article-title":"Relation of blood pressure with body and plasma electrolytes in Conn's syndrome","volume":"1","author":"Beretta-Piccoli","year":"1983","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1993.tb01778.x","article-title":"Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension","volume":"39","author":"Walker","year":"1993","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2006.07.001_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.HYP.25.1.67","article-title":"Evidence of coexisting changes in 11 beta-hydroxysteroid dehydrogenase and 5 beta-reductase activity in subjects with untreated essential hypertension","volume":"25","author":"Soro","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/beem.2000.0123","article-title":"Steroid metabolism in metabolic syndrome X","volume":"15","author":"Walker","year":"2001","journal-title":"Best Practice & Research. Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.HYP.31.4.891","article-title":"Increased glucocorticoid activity in men with cardiovascular risk factors","volume":"31","author":"Walker","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib47","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjhyper.2005.02.020","article-title":"Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension","volume":"18","author":"Mariniello","year":"2005","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/01.HYP.28.3.478","article-title":"Genetic association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks","volume":"28","author":"Watson","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib49","first-page":"1814","article-title":"A new polymorphic restriction site in the human 11 beta-hydroxysteroid dehydrogenase type 2 gene","volume":"83","author":"Smolenicka","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib50","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00004872-199816110-00009","article-title":"Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension","volume":"16","author":"Brand","year":"1998","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1523-1755.2005.67119.x","article-title":"Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides","volume":"67","author":"Williams","year":"2005","journal-title":"Kidney International"},{"key":"10.1016\/j.beem.2006.07.001_bib52","first-page":"3745","article-title":"Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2","volume":"84","author":"Lovati","year":"1999","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.HYP.36.2.187","article-title":"CA-Repeat polymorphism in intron 1 of HSD11B2: effects on gene expression and salt sensitivity","volume":"36","author":"Agarwal","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004872-200501000-00015","article-title":"Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives","volume":"23","author":"Carvajal","year":"2005","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2265.2001.01314.x","article-title":"Possible association but no linkage of the HSD11B2 gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase to hypertension in Black people","volume":"55","author":"White","year":"2001","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2006.07.001_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(71)90215-9","article-title":"Influence of hydrocortisone on cardiovascular responses to epinephrine","volume":"13","author":"Kadowitz","year":"1971","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.beem.2006.07.001_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(72)90209-9","article-title":"Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal","volume":"20","author":"Yard","year":"1972","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.beem.2006.07.001_bib58","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study","volume":"27","author":"Briegel","year":"1999","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.beem.2006.07.001_bib59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve","volume":"46","author":"Annane","year":"1998","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.beem.2006.07.001_bib60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/01.RES.9.1.153","article-title":"Potentiation of smooth muscle contraction by adrenal steroids","volume":"9","author":"Fowler","year":"1961","journal-title":"Circulation Research"},{"key":"10.1016\/j.beem.2006.07.001_bib61","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI115315","article-title":"Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells","volume":"88","author":"Sakaue","year":"1991","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.beem.2006.07.001_bib62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0008-6363(96)00053-3","article-title":"Potentiation of angiotensin II action by corticosteroids in vascular tissue","volume":"32","author":"Ullian","year":"1996","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.beem.2006.07.001_bib63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00004872-198712000-00018","article-title":"Aldosterone and dexamethasone binding in human arterial smooth muscle cells","volume":"5","author":"Scott","year":"1987","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib64","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0039-128X(94)00074-M","article-title":"Bidirectional activity of 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle cells","volume":"60","author":"Brem","year":"1995","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2006.07.001_bib65","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.35.5.1099","article-title":"Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries","volume":"35","author":"Alzamora","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib66","first-page":"207","article-title":"Effects of licorice derivatives on vascular smooth muscle function","volume":"60","author":"Brem","year":"1997","journal-title":"Life\u00a0Sciences"},{"key":"10.1016\/j.beem.2006.07.001_bib67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-128X(01)00148-9","article-title":"11 Beta-hydroxysteroid dehydrogenase antisense affects vascular contractile response and glucocorticoid metabolism","volume":"67","author":"Souness","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2006.07.001_bib68","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1523-1755.1998.00033.x","article-title":"Corticosterone and 11-dehydrocorticosterone stimulate Na,K-ATPase gene expression in vascular smooth muscle cells","volume":"54","author":"Muto","year":"1998","journal-title":"Kidney International"},{"key":"10.1016\/j.beem.2006.07.001_bib69","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00004872-200206000-00003","article-title":"The nitric oxide system in glucocorticoid-induced hypertension","volume":"20","author":"Whitworth","year":"2002","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib70","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/01.HYP.31.1.459","article-title":"Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells","volume":"31","author":"Brem","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.37.2.801","article-title":"Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension","volume":"37","author":"Quaschning","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib72","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1161\/hc4801.100077","article-title":"Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase","volume":"104","author":"Hadoke","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2006.07.001_bib73","first-page":"2519","article-title":"Steroidogenic enzyme gene expression in the human heart","volume":"85","author":"Kayes-Wandover","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib74","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.07.001_bib75","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2006.07.001_bib76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tem.2004.03.006","article-title":"Is aldosterone bad for the heart?","volume":"15","author":"Funder","year":"2004","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circulation Research"},{"key":"10.1016\/j.beem.2006.07.001_bib78","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"key":"10.1016\/j.beem.2006.07.001_bib79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00041552-200403000-00007","article-title":"Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease","volume":"13","author":"Gomez-Sanchez","year":"2004","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib80","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.beem.2006.07.001_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/frne.1996.0143","article-title":"11Beta-hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?","volume":"18","author":"Seckl","year":"1997","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.beem.2006.07.001_bib82","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1046\/j.1523-1755.2000.00971.x","article-title":"Brain mineralocorticoid receptors and centrally regulated functions","volume":"57","author":"De Kloet","year":"2000","journal-title":"Kidney International"},{"key":"10.1016\/j.beem.2006.07.001_bib83","first-page":"E1125","article-title":"Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone","volume":"263","author":"Gomez-Sanchez","year":"1992","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.beem.2006.07.001_bib84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.HYP.0000224296.96235.dd","article-title":"11{Beta}-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation","volume":"48","author":"Zhang","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1523\/JNEUROSCI.3115-05.2006","article-title":"Aldosterone target neurons in the nucleus tractus solitarius drive sodium appetite","volume":"26","author":"Geerling","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.beem.2006.07.001_bib86","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-0115(96)00048-1","article-title":"Increased sodium appetite and thirst in rat induced by the ingredients of liquorice, glycyrrhizic acid and glycyrrhetinic acid","volume":"66","author":"Cooney","year":"1996","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.beem.2006.07.001_bib87","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","article-title":"Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease","volume":"298","author":"Barker","year":"1989","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2006.07.001_bib88","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00004872-199608000-00002","article-title":"Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature","volume":"14","author":"Law","year":"1996","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib89","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00417.2005","article-title":"Fetal programming of hypertension","volume":"290","author":"Alexander","year":"2006","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"supplement 3","key":"10.1016\/j.beem.2006.07.001_bib90","doi-asserted-by":"crossref","first-page":"U49","DOI":"10.1530\/eje.0.151u049","article-title":"Prenatal glucocorticoids and long-term programming","volume":"151","author":"Seckl","year":"2004","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2006.07.001_bib91","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/01.HYP.27.6.1200","article-title":"Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring","volume":"27","author":"Lindsay","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0306-4522(01)00065-3","article-title":"Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour","volume":"104","author":"Welberg","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.beem.2006.07.001_bib93","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.HYP.0000049763.51269.51","article-title":"Prenatal dexamethasone programs hypertension and renal injury in the rat","volume":"41","author":"Ortiz","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2006.07.001_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0143-4004(96)80010-5","article-title":"Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat","volume":"17","author":"Langley-Evans","year":"1996","journal-title":"Placenta"},{"key":"10.1016\/j.beem.2006.07.001_bib95","first-page":"885","article-title":"Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis","volume":"80","author":"Stewart","year":"1995","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib96","first-page":"4979","article-title":"Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms","volume":"86","author":"McTernan","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2006.07.001_bib97","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1043-2760(02)00693-8","article-title":"Programmed hypertension: kidney, brain or both?","volume":"13","author":"Dodic","year":"2002","journal-title":"Trends in Endocrinology and Metabolism"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X06000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:38:08Z","timestamp":1761496688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X06000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1521690X06000479"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2006.07.001","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortisol metabolism in hypertension","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2006.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}